 | Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - April 3 at 5:10 PM |
 | Curis, Inc. (NASDAQ:CRIS) Sees Large Decline in Short Interest
www.americanbankingnews.com - March 28 at 5:00 PM |
| Edited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - March 26 at 9:14 PM |
| Edited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT
finance.yahoo.com - March 26 at 9:14 PM |
| Global Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Guide, 2020 - Therapeutics, Drugs, Players, and Developments - Yahoo Finance
finance.yahoo.com - March 25 at 6:33 PM |
| Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - March 21 at 5:28 PM |
| Curis (NASDAQ:CRIS) Releases Quarterly Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - March 20 at 9:41 AM |
 | BRIEF-Curis Reports Fourth Quarter And Year-End 2019 Financial Results And Provides Business Update - Reuters
www.reuters.com - March 19 at 10:33 PM |
| Curis, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - March 19 at 10:33 PM |
 | EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report
www.nasdaq.com - March 19 at 5:33 PM |
| Curis, Inc. to Host Earnings Call
finance.yahoo.com - March 19 at 5:33 PM |
| Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 19 at 5:33 PM |
| Curis, Inc. (CRIS)
finance.yahoo.com - March 19 at 7:32 AM |
| Curis (CRIS) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - March 13 at 9:49 AM |
| Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020 - Yahoo Finance
finance.yahoo.com - March 12 at 5:52 PM |
| Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020
finance.yahoo.com - March 12 at 12:51 PM |
| Layer 3 Platform FinNexus Will Hold World’s First ICTO on Bitrue Exchange - Yahoo Finance
finance.yahoo.com - March 4 at 8:06 AM |
| Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC - Yahoo Finance
finance.yahoo.com - February 27 at 12:16 PM |
| Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
finance.yahoo.com - February 27 at 12:16 PM |
| Healthfully Releases New Version of Integrated Consumer Health Platform - Yahoo Finance
finance.yahoo.com - February 27 at 7:16 AM |
 | Healthfully Releases New Version of Integrated Consumer Health Platform - PRNewswire
www.prnewswire.com - February 26 at 3:00 PM |
 | Optima Curis Rebrands to Healthfully - Benzinga
www.benzinga.com - February 21 at 9:08 AM |
| Optima Curis Rebrands to Healthfully - Yahoo Finance
finance.yahoo.com - February 20 at 5:45 PM |
| Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - Yahoo Finance
finance.yahoo.com - February 6 at 2:47 PM |
| Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - PRNewswire
www.prnewswire.com - February 6 at 9:46 AM |
| Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies - Yahoo Finance
finance.yahoo.com - January 13 at 8:58 PM |
| Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies
finance.yahoo.com - January 13 at 3:57 PM |
 | Curis up 9% premarket on deal with ImmuNext in cancer - Seeking Alpha
seekingalpha.com - January 9 at 4:02 AM |
| Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - January 8 at 4:33 PM |
| Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies - PRNewswire
www.prnewswire.com - January 7 at 10:19 AM |
| Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
finance.yahoo.com - January 7 at 10:18 AM |
| Curis up 9% premarket on deal with ImmuNext in cancer
seekingalpha.com - January 7 at 9:08 AM |
 | Jamie Lee Curis and Lin Shaye in 'The Grudge' are redefining, and empowering, scream queens - NBCNews.com
www.nbcnews.com - January 4 at 6:30 AM |
| Should You Buy Curis, Inc. (CRIS)? - Yahoo Finance
finance.yahoo.com - December 23 at 7:23 PM |
| The Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It - Yahoo Finance
finance.yahoo.com - December 22 at 12:14 PM |
| The Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It
finance.yahoo.com - December 22 at 12:14 PM |
| Clovis Oncology among healthcare gainers; Curis among losers - Seeking Alpha
seekingalpha.com - December 6 at 2:55 PM |
| Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study - PRNewswire
www.prnewswire.com - December 6 at 2:55 PM |
| Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study
finance.yahoo.com - December 6 at 9:54 AM |
| Curis To Present At Piper Jaffray Conference; Webcast At 11:30 AM ET - Nasdaq
www.nasdaq.com - December 3 at 1:14 PM |
| Edited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT - Yahoo Finance
finance.yahoo.com - November 20 at 6:08 PM |
| Edited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT
finance.yahoo.com - November 20 at 6:08 PM |
| Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - Yahoo Finance
finance.yahoo.com - November 8 at 8:46 AM |
| Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - PRNewswire
www.prnewswire.com - November 6 at 2:00 PM |
| Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology
finance.yahoo.com - November 6 at 2:00 PM |
| Curis Inc.'s (CRIS) CEO James Dentzer on Q3 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 5 at 11:11 PM |
| ImmunoGen among healthcare gainers; Curis and CHF Solutions among losers - Seeking Alpha
seekingalpha.com - November 5 at 1:10 PM |
| Curis Reports Third Quarter 2019 Financial Results - PRNewswire
www.prnewswire.com - November 5 at 8:09 AM |
| Curis Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 5 at 8:09 AM |
| /U P D A T E D -- Curis, Inc./ - Yahoo Finance
finance.yahoo.com - October 31 at 11:50 PM |
